VRTX

VERTEX PHARMACEUTICALS INC / MA

Sales chart range
Log in to watch VRTX
Latest sale
$548k
Nov 16 · Routine
Form 4 sales
1,509
On record
Form 144 notices
47
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    Jun 15 2026

    Sold 4,062 shares at $450.00 ($1.8M)

    Bozic Carmen, EVP and CMO

    10b5-1 planSold 19.3% of holdings ($9.5M position)16,953 shares left1.8x usual sizeFiling

  2. 2 Form 4 saleRoutine
    Jun 18 +3 days

    Sold 1,020 shares at $462.17 ($471k)

    Bozic Carmen, EVP and CMO

    10b5-1 planSold 6% of holdings ($7.8M position)15,933 shares left0.4x usual sizeFiling

  3. 3 Form 4 saleRoutine
    Jun 26 +8 days

    Sold 596 shares at $482.50 ($288k)

    Bozic Carmen, EVP and CMO

    10b5-1 planSold 3.7% of holdings ($7.7M position)15,337 shares left0.3x usual sizeFiling

  4. 4 Form 4 saleRoutine
    Jul 1 +5 days

    Sold 828 shares at $502.71 ($416k)

    Liu Joy, EVP and Chief Legal Officer

    10b5-1 planSold 4.1% of holdings ($10M position)19,131 shares left0.9x usual sizeFiling

  5. 5 Form 4 saleRoutine
    Jul 2 +1 day

    Sold 1,541 shares at $519.00 ($800k)

    McKechnie Duncan, EVP, Chief Commercial Officer

    10b5-1 planSold 12.3% of holdings ($6.5M position)11,001 shares left0.6x usual sizeFiling

  6. 6 Form 4 saleRoutine
    Jul 2 same day

    Sold 1,500 shares at $524.99 ($787k)

    Tatsis Ourania, EVP, Chief Reg. & Quality Off.

    10b5-1 planSold 3.2% of holdings ($24.6M position)45,321 shares left2x usual sizeFiling

  7. 7 Form 4 saleRoutine
    Nov 16 +137 days

    Sold 271 shares at $547.86 ($148k)

    Bhatia Sangeeta N., Director

    10b5-1 planSold 5.5% of holdings ($2.7M position)4,653 shares left0.9x usual sizeFiling

  8. 8 Form 4 saleRoutine
    Nov 16 same day

    Sold 1,000 shares at $547.86 ($548k)

    Thornberry Nancy, Director

    10b5-1 planSold 47.4% of holdings ($1.2M position)1,109 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales, notices and lockups (newest 400 of 1,556)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for VRTX
Source
Nov 16, 2026Thornberry NancyDirectorForm 4 sale1,000$548k47.4%RoutineSEC
Nov 16, 2026Bhatia Sangeeta N.DirectorForm 4 sale271$148k5.5%RoutineSEC
Jul 2, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale1,500$787k3.2%RoutineSEC
Jul 2, 2026McKechnie DuncanEVP, Chief Commercial OfficerForm 4 sale1,541$800k12.3%RoutineSEC
Jul 1, 2026Liu JoyEVP and Chief Legal OfficerForm 4 sale828$416k4.1%RoutineSEC
Jun 26, 2026Bozic CarmenEVP and CMOForm 4 sale596$288k3.7%RoutineSEC
Jun 18, 2026Bozic CarmenEVP and CMOForm 4 sale1,020$471k6.0%RoutineSEC
Jun 15, 2026Bozic CarmenEVP and CMOForm 4 sale4,062$1.8M19.3%RoutineSEC
Jun 5, 2026Bozic CarmenEVP and CMOForm 4 sale1,745$785k7.7%RoutineSEC
Jun 1, 2026Liu JoyEVP and Chief Legal OfficerForm 4 sale828$364k4.0%RoutineSEC
May 29, 2026Bozic CarmenEVP and CMOForm 4 sale1,974$888k8.0%RoutineSEC
May 15, 2026Bunnage Mark E.EVP, Chief Scientific OfficerForm 4 sale33$15k0.5%RoutineSEC
May 15, 2026Bozic CarmenEVP and CMOForm 4 sale1,354$614k5.2%RoutineSEC
May 12, 2026Bozic CarmenEVP and CMOForm 4 sale6,988$3.1M21.1%UnusualSEC
May 4, 2026Bhatia Sangeeta N.DirectorForm 4 sale318$135k6.1%RoutineSEC
May 1, 2026Liu JoyEVP and Chief Legal OfficerForm 4 sale1,104$469k5.1%RoutineSEC
Apr 1, 2026Liu JoyEVP and Chief Legal OfficerForm 4 sale978$439k4.3%RoutineSEC
Mar 27, 2026Bozic CarmenEVP and CMOForm 4 sale2,329$1.1M6.6%RoutineSEC
Mar 13, 2026Bozic CarmenEVP and CMOForm 4 sale2,329$1.1M6.2%RoutineSEC
Mar 11, 2026McKechnie DuncanEVP, Chief Commercial OfficerForm 4 sale2,633$1.3M17.4%RoutineSEC
Mar 4, 2026McKechnie DuncanEVP, Chief Commercial OfficerForm 4 sale2,437$1.2M13.9%RoutineSEC
Mar 2, 2026Liu JoyEVP and Chief Legal OfficerForm 4 sale892$442k3.8%RoutineSEC
Feb 27, 2026Kewalramani ReshmaCEO & PresidentForm 4 sale40,000$19.7M28.9%RoutineSEC
Feb 27, 2026Bozic CarmenEVP and CMOForm 4 sale2,329$1.1M5.8%RoutineSEC
Feb 26, 2026Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale357$173k5.1%RoutineSEC
Feb 25, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale260$126k0.6%RoutineSEC
Feb 25, 2026Sachdev AmitEVP Chief Patient & Ext Af OffForm 4 sale1,846$898k3.2%RoutineSEC
Feb 25, 2026McKechnie DuncanEVP, Chief Commercial OfficerForm 4 sale4,910$2.4M21.9%RoutineSEC
Feb 25, 2026Bunnage Mark E.EVP, Chief Scientific OfficerForm 4 sale620$302k7.8%RoutineSEC
Feb 25, 2026Biller JonathanEVP and Chief Legal OfficerForm 4 sale945$460k6.5%RoutineSEC
Feb 25, 2026Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale668$325k3.5%RoutineSEC
Feb 25, 2026Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale223$108k3.1%RoutineSEC
Feb 19, 2026Sachdev AmitEVP Chief Patient & Ext Af OffForm 4 sale58,613$27.5M49.9%UnusualSEC
Feb 18, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale977$472k2.0%RoutineSEC
Feb 18, 2026Bunnage Mark E.EVP, Chief Scientific OfficerForm 4 sale3,619$1.8M29.9%RoutineSEC
Feb 18, 2026Biller JonathanEVP and Chief Legal OfficerForm 4 sale3,720$1.8M19.1%UnusualSEC
Feb 18, 2026Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale2,848$1.4M12.1%RoutineSEC
Feb 18, 2026Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale2,195$1.1M22.1%RoutineSEC
Feb 13, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale1,500$750k3.1%RoutineSEC
Feb 13, 2026Biller JonathanEVP and Chief Legal OfficerForm 4 sale988$493k5.5%RoutineSEC
Feb 13, 2026Bhatia Sangeeta N.DirectorForm 4 sale266$133k5.8%RoutineSEC
Feb 11, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale466$215k0.9%RoutineSEC
Feb 11, 2026Bunnage Mark E.EVP, Chief Scientific OfficerForm 4 sale2,021$931k13.5%RoutineSEC
Feb 11, 2026Biller JonathanEVP and Chief Legal OfficerForm 4 sale1,925$886k8.5%RoutineSEC
Feb 11, 2026Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale1,751$806k7.4%RoutineSEC
Feb 11, 2026Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale1,376$634k12.0%RoutineSEC
Jan 7, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale4,500$2.1M9.6%UnusualSEC
Jan 6, 2026Wagner Charles F JrEVP, CO & FOForm 4 sale9,532$4.4M20.2%RoutineSEC
Dec 3, 2025Wagner Charles F JrEVP, CO & FOForm 4 sale14,000$6.4M27.1%UnusualSEC
Dec 3, 2025Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale4,500$2M8.8%UnusualSEC
Dec 3, 2025Leiden Jeffrey MExecutive ChairmanForm 4 sale63,781$28.7M72.6%UnusualSEC
Dec 3, 2025Biller JonathanEVP and Chief Legal OfficerForm 4 sale347$156k2.2%RoutineSEC
Nov 17, 2025Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale2,500$1.1M12.9%RoutineSEC
Nov 14, 2025Leiden Jeffrey MExecutive ChairmanForm 4 sale73,292$32.3M75.3%UnusualSEC
Oct 2, 2025Biller JonathanEVP and Chief Legal OfficerForm 4 sale694$281k4.2%RoutineSEC
Aug 27, 2025Bhatia Sangeeta N.DirectorForm 4 sale266$103k5.5%RoutineSEC
May 15, 2025Altshuler DavidEVP, Chief Scientific OfficerForm 4 sale52$22k0.2%RoutineSEC
May 2, 2025Bhatia Sangeeta N.DirectorForm 4 sale400$202k7.6%RoutineSEC
Mar 13, 2025Altshuler DavidEVP, Chief Scientific OfficerForm 4 sale3,231$1.6M12.2%RoutineSEC
Mar 10, 2025Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale3,298$1.6M6.0%RoutineSEC
Mar 10, 2025Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale3,242$1.6M6.0%UnusualSEC
Mar 10, 2025Altshuler DavidEVP, Chief Scientific OfficerForm 4 sale3,231$1.6M10.9%RoutineSEC
Mar 4, 2025Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale4,058$2M6.9%UnusualSEC
Mar 3, 2025Altshuler DavidEVP, Chief Scientific OfficerForm 4 sale3,231$1.6M9.8%RoutineSEC
Feb 27, 2025Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale530$252k0.9%RoutineSEC
Feb 27, 2025Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale2,650$1.3M12.0%RoutineSEC
Feb 27, 2025Altshuler DavidEVP, Chief Scientific OfficerForm 4 sale1,272$611k3.7%RoutineSEC
Feb 25, 2025Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale354$170k0.5%RoutineSEC
Feb 25, 2025Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale1,767$850k6.7%RoutineSEC
Feb 25, 2025Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale884$425k8.9%RoutineSEC
Feb 25, 2025Altshuler DavidEVP, Chief Scientific OfficerForm 4 sale848$408k2.1%RoutineSEC
Feb 20, 2025Altshuler DavidEVP, Chief Scientific OfficerForm 4 sale1,111$533k2.4%RoutineSEC
Feb 18, 2025Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale244$111k0.4%RoutineSEC
Feb 18, 2025Biller JonathanEVP and Chief Legal OfficerForm 4 sale1,657$754k8.6%RoutineSEC
Feb 18, 2025Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale671$305k5.9%RoutineSEC
Feb 11, 2025Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale310$143k0.5%RoutineSEC
Feb 11, 2025Biller JonathanEVP and Chief Legal OfficerForm 4 sale3,433$1.6M17.4%UnusualSEC
Feb 11, 2025Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale1,747$803k7.0%RoutineSEC
Feb 11, 2025Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale1,376$633k12.1%RoutineSEC
Nov 15, 2024Altshuler DavidEVP, Chief Scientific OfficerForm 4 sale15$7k0.1%RoutineSEC
Nov 11, 2024Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale3,000$1.6M6.4%RoutineSEC
Nov 8, 2024Kewalramani ReshmaCEO & PresidentForm 4 sale15,198$7.8M16.7%RoutineSEC
Oct 2, 2024Biller JonathanEVP and Chief Legal OfficerForm 4 sale999$461k5.7%RoutineSEC
Aug 30, 2024Leiden Jeffrey MExecutive ChairmanForm 4 sale3,784$1.9M27.5%RoutineSEC
Aug 30, 2024Bhatia Sangeeta N.DirectorForm 4 sale646$323k12.7%RoutineSEC
Aug 8, 2024Bhatia Sangeeta N.DirectorForm 4 sale1,292$602k22.6%UnusualSEC
Aug 7, 2024Bozic CarmenEVP and CMOForm 4 sale2,280$1.1M8.9%RoutineSEC
Aug 1, 2024Sachs Bruce IDirectorForm 4 sale5,295$2.7M11.7%RoutineSEC
Jul 30, 2024Kewalramani ReshmaCEO & PresidentForm 4 sale15,202$7.7M14.3%RoutineSEC
Jul 24, 2024Bozic CarmenEVP and CMOForm 4 sale2,280$1.1M8.2%RoutineSEC
Jul 22, 2024Kewalramani ReshmaCEO & PresidentForm 4 sale15,202$7.6M12.5%RoutineSEC
Jul 10, 2024Bozic CarmenEVP and CMOForm 4 sale2,280$1.1M7.6%RoutineSEC
Jun 26, 2024Bozic CarmenEVP and CMOForm 4 sale2,280$1.1M7.0%RoutineSEC
Jun 12, 2024Bozic CarmenEVP and CMOForm 4 sale2,280$1.1M6.6%RoutineSEC
Jun 12, 2024Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale7,288$3.5M31.3%UnusualSEC
Jun 3, 2024Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale3,250$1.5M6.5%RoutineSEC
Jun 3, 2024Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale2,175$1M4.2%UnusualSEC
May 31, 2024Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale4,600$2M8.2%UnusualSEC
May 29, 2024Bozic CarmenEVP and CMOForm 4 sale2,280$1M6.2%RoutineSEC
May 28, 2024Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale3,250$1.5M6.1%RoutineSEC
May 24, 2024Kewalramani ReshmaCEO & PresidentForm 4 sale1,565$715k1.3%RoutineSEC
May 22, 2024Sachs Bruce IDirectorForm 4 sale7,073$3.2M15.0%RoutineSEC
May 20, 2024Kewalramani ReshmaCEO & PresidentForm 4 sale15,202$6.8M11.1%RoutineSEC
May 15, 2024Sachdev AmitEVP Chief Patient & Ext Af OffForm 4 sale32$14k0.1%RoutineSEC
May 15, 2024Arbuckle Stuart AEVP, COOForm 4 sale69$30k0.1%RoutineSEC
May 15, 2024Altshuler DavidEVP, Chief Scientific OfficerForm 4 sale54$23k0.2%RoutineSEC
May 2, 2024Bhatia Sangeeta N.DirectorForm 4 sale467$188k9.5%RoutineSEC
Apr 2, 2024Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale240$101k3.1%RoutineSEC
Feb 26, 2024Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale354$151k0.6%RoutineSEC
Feb 26, 2024Sachdev AmitEVP Chief Patient & Ext Af OffForm 4 sale3,004$1.3M5.2%RoutineSEC
Feb 26, 2024Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale883$376k5.2%RoutineSEC
Feb 26, 2024Arbuckle Stuart AEVP, COOForm 4 sale5,034$2.1M9.2%RoutineSEC
Feb 26, 2024Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale883$376k10.0%RoutineSEC
Feb 26, 2024Altshuler DavidEVP, Global Research and CSOForm 4 sale4,239$1.8M14.1%RoutineSEC
Feb 21, 2024Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale360$152k0.6%RoutineSEC
Feb 21, 2024Sachdev AmitEVP Chief Patient & Ext Af OffForm 4 sale3,191$1.3M5.0%RoutineSEC
Feb 21, 2024Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale1,201$507k6.1%RoutineSEC
Feb 21, 2024Arbuckle Stuart AEVP, COOForm 4 sale3,603$1.5M5.7%RoutineSEC
Feb 21, 2024Altshuler DavidEVP, Global Research and CSOForm 4 sale3,002$1.3M8.1%RoutineSEC
Feb 20, 2024Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale480$202k0.8%RoutineSEC
Feb 20, 2024Sachdev AmitEVP Chief Patient & Ext Af OffForm 4 sale4,254$1.8M6.2%RoutineSEC
Feb 20, 2024Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale801$337k3.9%RoutineSEC
Feb 20, 2024Arbuckle Stuart AEVP, COOForm 4 sale4,804$2M7.1%RoutineSEC
Feb 20, 2024Altshuler DavidEVP, Global Research and CSOForm 4 sale4,002$1.7M9.8%RoutineSEC
Feb 15, 2024Leiden Jeffrey MExecutive ChairmanForm 4 sale9,011$3.8M33.5%RoutineSEC
Feb 13, 2024Leiden Jeffrey MExecutive ChairmanForm 4 sale3,393$1.4M11.2%RoutineSEC
Feb 12, 2024Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale314$132k0.5%RoutineSEC
Feb 12, 2024Sachdev AmitEVP Chief Patient & Ext Af OffForm 4 sale3,222$1.4M4.2%RoutineSEC
Feb 12, 2024Biller JonathanEVP and Chief Legal OfficerForm 4 sale1,738$728k8.7%RoutineSEC
Feb 12, 2024Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Form 4 sale913$384k3.8%RoutineSEC
Feb 12, 2024Arbuckle Stuart AEVP, COOForm 4 sale4,295$1.8M5.4%RoutineSEC
Feb 12, 2024Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale1,374$577k12.4%UnusualSEC
Feb 12, 2024Altshuler DavidEVP, Global Research and CSOForm 4 sale3,145$1.3M6.2%RoutineSEC
Jan 8, 2024Leiden Jeffrey MExecutive ChairmanForm 4 sale6,648$2.8M73.3%RoutineSEC
Jan 2, 2024Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale3,000$1.2M6.4%RoutineSEC
Dec 15, 2023Kewalramani ReshmaCEO & PresidentForm 4 sale17,135$7M13.6%RoutineSEC
Dec 15, 2023Kewalramani ReshmaOfficer, DirectorForm 144 notice17,135$7MNoticeSEC
Dec 13, 2023Leiden Jeffrey MExecutive ChairmanForm 4 sale13,354$5.3M59.5%RoutineSEC
Dec 13, 2023Kewalramani ReshmaCEO & PresidentForm 4 sale5,098$2M4.5%RoutineSEC
Dec 13, 2023Arbuckle Stuart AEVP, COOForm 4 sale8,603$3.4M13.2%RoutineSEC
Dec 13, 2023Leiden Jeffrey MDirectorForm 144 notice13,354$5.3MNoticeSEC
Dec 13, 2023Kewalramani ReshmaOfficer, DirectorForm 144 notice5,098$2MNoticeSEC
Dec 13, 2023Arbuckle Stuart AOfficerForm 144 notice8,603$3.4MNoticeSEC
Nov 20, 2023Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale3,000$1M6.0%RoutineSEC
Nov 20, 2023Wagner Charles F JrOfficerForm 144 notice3,000$1MNoticeSEC
Nov 15, 2023Sachdev AmitEVP Chief Patient & Ext Af OffForm 4 sale35$13k0.1%RoutineSEC
Nov 15, 2023Altshuler DavidEVP, Global Research and CSOForm 4 sale19$7k0.1%RoutineSEC
Nov 15, 2023Altshuler DavidOfficerForm 144 notice19$7kNoticeSEC
Nov 15, 2023Sachdev AmitOfficerForm 144 notice35$13kNoticeSEC
Nov 14, 2023Bozic CarmenEVP and CMOForm 4 sale5,650$2.2M16.2%RoutineSEC
Nov 14, 2023Bozic CarmenOfficerForm 144 notice5,650$2.2MNoticeSEC
Nov 13, 2023Kewalramani ReshmaCEO & PresidentForm 4 sale5,097$1.9M4.3%RoutineSEC
Nov 13, 2023Kewalramani ReshmaOfficer, DirectorForm 144 notice5,097$1.9MNoticeSEC
Nov 6, 2023Sachs Bruce IDirectorForm 4 sale11,250$4.3M22.0%RoutineSEC
Nov 6, 2023Sachs Bruce IDirectorForm 144 notice11,250$4.3MNoticeSEC
Oct 31, 2023Bozic CarmenEVP and CMOForm 4 sale5,651$2M13.9%RoutineSEC
Oct 31, 2023Bozic CarmenOfficerForm 144 notice5,651$2MNoticeSEC
Oct 17, 2023Bozic CarmenEVP and CMOForm 4 sale5,651$2.1M12.2%RoutineSEC
Oct 17, 2023Bhatia Sangeeta N.DirectorForm 4 sale243$91k5.9%RoutineSEC
Oct 17, 2023Bhatia Sangeeta N.DirectorForm 144 notice243$91kNoticeSEC
Oct 17, 2023Bozic CarmenOfficerForm 144 notice5,651$2.1MNoticeSEC
Oct 16, 2023Leiden Jeffrey MExecutive ChairmanForm 4 sale12,962$4.8M36.6%RoutineSEC
Oct 16, 2023Leiden Jeffrey MDirectorForm 144 notice12,962$4.8MNoticeSEC
Oct 6, 2023Bhatia Sangeeta N.DirectorForm 4 sale242$87k5.5%RoutineSEC
Oct 6, 2023Bhatia Sangeeta N.DirectorForm 144 notice242$87kNoticeSEC
Oct 3, 2023Bozic CarmenEVP and CMOForm 4 sale5,651$2M10.9%RoutineSEC
Oct 3, 2023Bozic CarmenOfficerForm 144 notice5,651$2MNoticeSEC
Oct 2, 2023Biller JonathanEVP and Chief Legal OfficerForm 4 sale610$212k5.5%RoutineSEC
Oct 2, 2023Biller JonathanOfficerForm 144 notice610$212kNoticeSEC
Sep 19, 2023Bozic CarmenEVP and CMOForm 4 sale5,651$2M9.8%RoutineSEC
Sep 19, 2023Bozic CarmenOfficerForm 144 notice5,651$2MNoticeSEC
Sep 5, 2023Bozic CarmenEVP and CMOForm 4 sale5,651$2M8.9%RoutineSEC
Sep 5, 2023Bozic CarmenOfficerForm 144 notice5,651$2MNoticeSEC
Aug 23, 2023Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale2,500$888k4.9%UnusualSEC
Aug 23, 2023Tatsis OuraniaOfficerForm 144 notice2,500$888kNoticeSEC
Aug 10, 2023Kearney Terrence CDirectorForm 4 sale10,000$3.5M60.5%RoutineSEC
Aug 10, 2023Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale5,750$2M10.1%UnusualSEC
Aug 10, 2023Sachdev AmitEVP, Chief Patient OfficerForm 4 sale10,031$3.5M14.6%RoutineSEC
Aug 10, 2023Kearney Terrence CDirectorForm 144 notice10,000$3.5MNoticeSEC
Aug 10, 2023Sachdev AmitOfficerForm 144 notice10,031$3.5MNoticeSEC
Aug 10, 2023Tatsis OuraniaOfficerForm 144 notice5,750$2MNoticeSEC
Aug 9, 2023Altshuler DavidEVP, Global Research and CSOForm 4 sale63$22k0.2%RoutineSEC
Aug 9, 2023Bhatia Sangeeta N.DirectorForm 4 sale242$84k5.2%RoutineSEC
Aug 9, 2023Bhatia Sangeeta N.DirectorForm 144 notice242$84kNoticeSEC
Aug 9, 2023Altshuler DavidOfficerForm 144 notice63$22kNoticeSEC
Jul 17, 2023Sachs Bruce IDirectorForm 4 sale11,250$4M22.0%RoutineSEC
Jul 17, 2023Kewalramani ReshmaCEO & PresidentForm 4 sale7,828$2.8M6.2%RoutineSEC
Jul 17, 2023Kewalramani ReshmaOfficer, DirectorForm 144 notice7,828$2.8MNoticeSEC
Jul 17, 2023Sachs Bruce IDirectorForm 144 notice11,250$4MNoticeSEC
Jun 15, 2023Arbuckle Stuart AEVP, COOForm 4 sale8,603$3M13.2%UnusualSEC
Jun 15, 2023Arbuckle Stuart AOfficerForm 144 notice8,603$3MNoticeSEC
May 30, 2023Arbuckle Stuart AEVP, COOForm 4 sale82$27k0.1%RoutineSEC
May 30, 2023Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale289$95k4.1%RoutineSEC
May 30, 2023Arbuckle Stuart AOfficerForm 144 notice82$27kNoticeSEC
May 8, 2023Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale3,272$1.1M9.3%UnusualSEC
May 8, 2023Leiden Jeffrey MExecutive ChairmanForm 4 sale2,004$700k5.4%RoutineSEC
May 8, 2023Sanna BastianoOfficerForm 144 notice2,850$998kNoticeSEC
May 8, 2023Leiden Jeffrey MDirectorForm 144 notice1,125$393kNoticeSEC
May 5, 2023Sanna BastianoOfficerForm 144 notice422$148kNoticeSEC
May 5, 2023Leiden Jeffrey MDirectorForm 144 notice879$307kNoticeSEC
May 3, 2023Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale4,403$1.5M11.1%UnusualSEC
May 3, 2023Leiden Jeffrey MExecutive ChairmanForm 4 sale10,958$3.8M22.7%RoutineSEC
May 3, 2023Sanna BastianoOfficerForm 144 notice2,781$975kNoticeSEC
May 3, 2023Leiden Jeffrey MDirectorForm 144 notice4,508$1.6MNoticeSEC
May 2, 2023Bhatia Sangeeta N.DirectorForm 4 sale580$202k11.1%RoutineSEC
May 2, 2023Sanna BastianoOfficerForm 144 notice1,622$569kNoticeSEC
May 2, 2023Leiden Jeffrey MDirectorForm 144 notice6,450$2.3MNoticeSEC
May 2, 2023Bhatia Sangeeta N.DirectorForm 144 notice580$200kNoticeSEC
Apr 27, 2023Kewalramani ReshmaCEO & PresidentForm 4 sale3,317$1.1M2.6%RoutineSEC
Apr 27, 2023Kewalramani ReshmaOfficer, DirectorForm 144 notice3,317$1.1MNoticeSEC
Apr 12, 2023Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale7,567$2.5M16.0%UnusualSEC
Apr 12, 2023Sachs Bruce IDirectorForm 4 sale21,300$7M34.1%RoutineSEC
Apr 12, 2023Sanna BastianoOfficerForm 144 notice7,567$2.5MNoticeSEC
Apr 12, 2023Sachs Bruce IDirectorForm 144 notice21,300$7MNoticeSEC
Apr 4, 2023Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale522$165k1.1%RoutineSEC
Apr 4, 2023Sanna BastianoOfficerForm 144 notice522$165kNoticeSEC
Mar 24, 2023Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale1,768$540k3.4%RoutineSEC
Mar 24, 2023Wagner Charles F JrOfficerForm 144 notice1,768$540kNoticeSEC
Mar 17, 2023Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale2,000$593k3.7%RoutineSEC
Mar 17, 2023Wagner Charles F JrOfficerForm 144 notice2,000$600kNoticeSEC
Mar 16, 2023Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale2,746$825k5.3%UnusualSEC
Mar 16, 2023Sanna BastianoOfficerForm 144 notice2,746$825kNoticeSEC
Mar 13, 2023Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale4,754$1.4M8.2%Plan not statedSEC
Mar 13, 2023Wagner Charles F JrOfficerForm 144 notice2,666$783kNoticeSEC
Mar 10, 2023Wagner Charles F JrOfficerForm 144 notice2,088$605kNoticeSEC
Feb 27, 2023Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale354$102k0.6%Plan not statedSEC
Feb 27, 2023Arbuckle Stuart AEVP, COOForm 4 sale5,034$1.4M8.2%Plan not statedSEC
Feb 27, 2023Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale1,207$347k14.2%Plan not statedSEC
Feb 27, 2023Altshuler DavidEVP, Global Research and CSOForm 4 sale4,238$1.2M11.7%Plan not statedSEC
Feb 22, 2023Arbuckle Stuart AEVP, COOForm 4 sale2,401$707k3.5%Plan not statedSEC
Feb 21, 2023Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale480$141k0.8%Plan not statedSEC
Feb 21, 2023Arbuckle Stuart AEVP, COOForm 4 sale2,402$706k3.4%Plan not statedSEC
Feb 21, 2023Altshuler DavidEVP, Global Research and CSOForm 4 sale4,002$1.2M9.0%Plan not statedSEC
Feb 14, 2023Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale320$96k0.5%Plan not statedSEC
Feb 14, 2023Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale2,181$655k3.5%UnusualSEC
Feb 14, 2023Arbuckle Stuart AEVP, COOForm 4 sale6,398$1.9M7.8%UnusualSEC
Feb 14, 2023Altshuler DavidEVP, Global Research and CSOForm 4 sale6,398$1.9M11.8%Plan not statedSEC
Feb 13, 2023Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale275$82k0.4%Plan not statedSEC
Feb 13, 2023Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale113$34k0.2%Plan not statedSEC
Feb 13, 2023Arbuckle Stuart AEVP, COOForm 4 sale4,887$1.5M5.6%UnusualSEC
Feb 13, 2023Altshuler DavidEVP, Global Research and CSOForm 4 sale4,798$1.4M8.1%Plan not statedSEC
Feb 6, 2023Altshuler DavidEVP, Global Research and CSOForm 4 sale1,304$399k1.9%Plan not statedSEC
Jan 31, 2023Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale106$34k0.3%Plan not statedSEC
Jan 31, 2023Sachs Bruce IDirectorForm 4 sale1,200$390k2.8%Plan not statedSEC
Jan 30, 2023Carney LloydDirectorForm 4 sale2,700$865k39.4%UnusualSEC
Jan 27, 2023Lee YuchunDirectorForm 4 sale1,429$460k43.3%UnusualSEC
Jan 26, 2023Lee YuchunDirectorForm 4 sale8,000$2.5M81.0%UnusualSEC
Jan 25, 2023Kewalramani ReshmaCEO & PresidentForm 4 sale10,000$3.2M10.0%Plan not statedSEC
Jan 24, 2023Lee YuchunDirectorForm 4 sale6,129$1.9M76.6%UnusualSEC
Jan 18, 2023Lee YuchunDirectorForm 4 sale4,442$1.4M70.3%UnusualSEC
Nov 15, 2022Altshuler DavidEVP, Global Research and CSOForm 4 sale34$10k0.1%Plan not statedSEC
Nov 7, 2022Altshuler DavidEVP, Global Research and CSOForm 4 sale1,303$395k3.5%Plan not statedSEC
Nov 2, 2022Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale320$100k0.8%Plan not statedSEC
Oct 24, 2022Bhatia Sangeeta N.DirectorForm 4 sale621$193k13.3%Plan not statedSEC
Oct 18, 2022Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale1,791$538k4.4%Plan not statedSEC
Aug 15, 2022Kewalramani ReshmaCEO & PresidentForm 4 sale11,689$3.6M10.5%Plan not statedSEC
Aug 15, 2022Arbuckle Stuart AEVP, COOForm 4 sale22,173$6.7M32.9%UnusualSEC
Aug 15, 2022Liu JoySVP, General CounselForm 4 sale3,747$1.1M28.1%UnusualSEC
Aug 10, 2022Arbuckle Stuart AEVP, COOForm 4 sale180$54k0.3%Plan not statedSEC
Aug 10, 2022Liu JoySVP, General CounselForm 4 sale36$11k0.3%Plan not statedSEC
Aug 9, 2022Liu JoySVP, General CounselForm 4 sale946$284k6.6%UnusualSEC
Aug 9, 2022Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale1,400$419k2.9%UnusualSEC
Aug 9, 2022Arbuckle Stuart AEVP, COOForm 4 sale5,690$1.7M8.5%UnusualSEC
Aug 8, 2022Bhatia Sangeeta N.DirectorForm 4 sale621$182k11.8%Plan not statedSEC
Aug 8, 2022Altshuler DavidEVP, Global Research and CSOForm 4 sale1,304$381k3.5%Plan not statedSEC
Jul 29, 2022Bhatia Sangeeta N.DirectorForm 4 sale621$173k10.5%Plan not statedSEC
Jul 25, 2022Leiden Jeffrey MExecutive ChairmanForm 4 sale132,079$37.2M98.2%UnusualSEC
Jul 19, 2022Altshuler DavidEVP, Global Research and CSOForm 4 sale17,865$5.2M33.1%UnusualSEC
Jun 24, 2022Kewalramani ReshmaCEO & PresidentForm 4 sale11,689$3.4M9.5%Plan not statedSEC
May 16, 2022Arbuckle Stuart AEVP, COOForm 4 sale133$33k0.2%Plan not statedSEC
May 16, 2022Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale45$11k0.1%Plan not statedSEC
May 16, 2022Liu JoySVP, General CounselForm 4 sale133$34k0.9%Plan not statedSEC
May 4, 2022Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale36$10k0.1%Plan not statedSEC
May 2, 2022Arbuckle Stuart AEVP, COOForm 4 sale306$81k0.5%Plan not statedSEC
May 2, 2022Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale320$83k0.8%Plan not statedSEC
May 2, 2022Bhatia Sangeeta N.DirectorForm 4 sale737$191k11.1%Plan not statedSEC
May 2, 2022Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale343$89k0.8%Plan not statedSEC
Apr 29, 2022Liu JoySVP, General CounselForm 4 sale120$33k0.8%Plan not statedSEC
Apr 25, 2022Ambrose KristenSVP & Chief Accounting OfficerForm 4 sale327$88k8.6%Plan not statedSEC
Apr 18, 2022Lee YuchunDirectorForm 4 sale2,000$568k51.6%UnusualSEC
Apr 14, 2022Lee YuchunDirectorForm 4 sale2,000$578k51.6%UnusualSEC
Apr 13, 2022Leiden Jeffrey MExecutive ChairmanForm 4 sale15,789$4.6M17.6%Plan not statedSEC
Apr 13, 2022Lee YuchunDirectorForm 4 sale4,000$1.1M68.1%UnusualSEC
Apr 11, 2022Lee YuchunDirectorForm 4 sale4,000$1.1M68.1%UnusualSEC
Apr 8, 2022Bhatia Sangeeta N.DirectorForm 4 sale1,907$534k26.9%UnusualSEC
Apr 8, 2022Mcglynn Margaret GDirectorForm 4 sale5,000$1.4M82.0%UnusualSEC
Apr 7, 2022Lee YuchunDirectorForm 4 sale4,000$1.1M68.1%UnusualSEC
Apr 7, 2022Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale561$155k1.3%Plan not statedSEC
Apr 5, 2022Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale3,725$1M7.9%Plan not statedSEC
Apr 5, 2022Lee YuchunDirectorForm 4 sale4,000$1.1M68.1%UnusualSEC
Apr 1, 2022Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale2,582$684k5.6%Plan not statedSEC
Mar 31, 2022Mcglynn Margaret GDirectorForm 4 sale5,000$1.3M82.0%UnusualSEC
Mar 17, 2022Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale2,833$709k5.6%UnusualSEC
Mar 17, 2022Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale3,171$793k6.4%Plan not statedSEC
Mar 17, 2022Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale2,122$531k4.2%Plan not statedSEC
Feb 25, 2022Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale325$75k0.6%Plan not statedSEC
Feb 25, 2022Altshuler DavidEVP, Global Research and CSOForm 4 sale7,572$1.7M17.3%UnusualSEC
Feb 18, 2022Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale519$120k1.0%Plan not statedSEC
Feb 18, 2022Altshuler DavidEVP, Global Research and CSOForm 4 sale4,312$996k8.0%Plan not statedSEC
Feb 14, 2022Altshuler DavidEVP, Global Research and CSOForm 4 sale2,444$567k4.1%Plan not statedSEC
Feb 11, 2022Tatsis OuraniaEVP, Chief Reg. & Quality Off.Form 4 sale290$68k0.5%Plan not statedSEC
Feb 11, 2022Altshuler DavidEVP, Global Research and CSOForm 4 sale2,297$540k3.7%Plan not statedSEC
Feb 2, 2022Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale2,944$736k4.9%Plan not statedSEC
Feb 2, 2022Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale1,040$261k1.9%Plan not statedSEC
Feb 2, 2022Altshuler DavidEVP, Global Research and CSOForm 4 sale4,660$1.2M6.6%Plan not statedSEC
Jan 28, 2022Mcglynn Margaret GDirectorForm 4 sale5,000$1.2M82.0%UnusualSEC
Nov 15, 2021Sachdev AmitEVP, Chief Patient OfficerForm 4 sale51$10k0.2%Plan not statedSEC
Nov 15, 2021Arbuckle Stuart AEVP, COOForm 4 sale3$5620.0%Plan not statedSEC
Nov 15, 2021Altshuler DavidEVP, Global Research and CSOForm 4 sale34$6k0.1%Plan not statedSEC
Jun 2, 2021Bhatia Sangeeta N.DirectorForm 4 sale559$117k9.7%Plan not statedSEC
May 17, 2021Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale112$24k0.3%Plan not statedSEC
May 17, 2021Sachdev AmitEVP, Chief Patient OfficerForm 4 sale45$10k0.1%Plan not statedSEC
May 17, 2021Liu JoySVP, General CounselForm 4 sale112$24k1.3%Plan not statedSEC
May 17, 2021Arbuckle Stuart AEVP, Chief Comm & Ops OfficerForm 4 sale109$24k0.3%Plan not statedSEC
May 17, 2021Altshuler DavidEVP, Global Research and CSOForm 4 sale79$17k0.2%Plan not statedSEC
May 3, 2021Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale960$210k2.7%Plan not statedSEC
Apr 27, 2021Sachdev AmitEVP, Chief Patient OfficerForm 4 sale3,884$839k8.8%Plan not statedSEC
Apr 5, 2021Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale1,686$361k4.5%Plan not statedSEC
Mar 5, 2021Liu JoySVP, General CounselForm 4 sale5,141$1.1M38.4%UnusualSEC
Mar 1, 2021Silva Paul MSVP & Chief Accounting OfficerForm 4 sale2,782$588k22.0%Plan not statedSEC
Feb 25, 2021Silva Paul MSVP & Chief Accounting OfficerForm 4 sale1,080$231k6.8%Plan not statedSEC
Feb 25, 2021Sachdev AmitEVP, Chief Patient OfficerForm 4 sale3,586$765k8.2%Plan not statedSEC
Feb 25, 2021Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale3,028$646k8.9%Plan not statedSEC
Feb 25, 2021Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale3,634$776k8.1%Plan not statedSEC
Feb 25, 2021Altshuler DavidEVP, Global Research and CSOForm 4 sale3,028$646k8.3%Plan not statedSEC
Feb 18, 2021Silva Paul MSVP & Chief Accounting OfficerForm 4 sale4,295$910k20.3%UnusualSEC
Feb 18, 2021Sachdev AmitEVP, Chief Patient OfficerForm 4 sale9,264$2M16.6%Plan not statedSEC
Feb 18, 2021Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale7,825$1.7M17.7%UnusualSEC
Feb 18, 2021Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale7,825$1.7M14.1%Plan not statedSEC
Feb 18, 2021Altshuler DavidEVP, Global Research and CSOForm 4 sale7,825$1.7M16.7%UnusualSEC
Feb 11, 2021Silva Paul MSVP & Chief Accounting OfficerForm 4 sale1,498$315k5.9%Plan not statedSEC
Feb 11, 2021Sanna BastianoEVP, Cell & Genetic TherapiesForm 4 sale1,686$355k4.2%Plan not statedSEC
Feb 11, 2021Sachdev AmitEVP, Chief Patient OfficerForm 4 sale4,460$939k6.6%Plan not statedSEC
Feb 11, 2021Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale4,318$909k7.9%Plan not statedSEC
Feb 11, 2021Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale5,156$1.1M7.7%Plan not statedSEC
Feb 11, 2021Altshuler DavidEVP, Global Research and CSOForm 4 sale5,283$1.1M9.0%Plan not statedSEC
Feb 5, 2021Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale1,930$415k3.3%Plan not statedSEC
Feb 3, 2021Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale400$87k0.7%Plan not statedSEC
Feb 3, 2021Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale1,554$332k2.2%Plan not statedSEC
Nov 16, 2020Sachdev AmitEVP, Chief Patient OfficerForm 4 sale42$9k0.1%Plan not statedSEC
Nov 16, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale91$20k0.3%Plan not statedSEC
Nov 16, 2020Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale7$2k0.0%Plan not statedSEC
Nov 16, 2020Altshuler DavidEVP, Global Research and CSOForm 4 sale38$8k0.1%Plan not statedSEC
Nov 4, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale2,330$507k8.0%Plan not statedSEC
Nov 3, 2020Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale1,553$329k4.2%Plan not statedSEC
Oct 5, 2020Bhatia Sangeeta N.DirectorForm 4 sale10,516$2.8M72.9%UnusualSEC
Aug 6, 2020Silva Paul MSVP & ControllerForm 4 sale1,078$292k6.7%Plan not statedSEC
Aug 6, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale1,223$332k4.4%Plan not statedSEC
Aug 6, 2020Kewalramani ReshmaCEO & PresidentForm 4 sale2,073$562k7.2%Plan not statedSEC
Aug 6, 2020Altshuler DavidEVP, Global Research and CSOForm 4 sale1,223$332k4.1%Plan not statedSEC
Aug 3, 2020Sachdev AmitEVP, Chief Patient OfficerForm 4 sale1,941$540k5.2%Plan not statedSEC
Aug 3, 2020Silva Paul MSVP & ControllerForm 4 sale809$225k5.1%Plan not statedSEC
Aug 3, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale2,330$648k8.0%Plan not statedSEC
Aug 3, 2020Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale1,553$432k4.2%Plan not statedSEC
Aug 3, 2020Altshuler DavidEVP, Global Research and CSOForm 4 sale2,330$648k7.5%Plan not statedSEC
Jul 13, 2020Silva Paul MSVP & ControllerForm 4 sale860$251k5.4%Plan not statedSEC
Jul 13, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale2,125$621k7.3%Plan not statedSEC
Jul 10, 2020Wagner Charles F JrEVP & Chief Financial OfficerForm 4 sale700$205k4.2%Plan not statedSEC
Jul 7, 2020Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale2,786$836k7.3%Plan not statedSEC
Jun 30, 2020Leiden Jeffrey MExecutive ChairmanForm 4 sale32,792$9.4M93.5%UnusualSEC
Jun 2, 2020Bhatia Sangeeta N.DirectorForm 4 sale952$269k14.3%Plan not statedSEC
May 15, 2020Kewalramani ReshmaCEO & PresidentForm 4 sale99$28k0.4%Plan not statedSEC
May 15, 2020Tatsis OuraniaEVP, Chief Regulatory OfficerForm 4 sale120$34k0.9%Plan not statedSEC
May 15, 2020Silva Paul MSVP & ControllerForm 4 sale151$43k1.0%Plan not statedSEC
May 15, 2020Sachdev AmitEVP, Chief Patient OfficerForm 4 sale58$16k0.2%Plan not statedSEC
May 15, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale68$19k0.3%Plan not statedSEC
May 15, 2020Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale113$32k0.3%Plan not statedSEC
May 15, 2020Altshuler DavidEVP, Global Research and CSOForm 4 sale82$23k0.3%Plan not statedSEC
May 12, 2020Leiden Jeffrey MExecutive ChairmanForm 4 sale94,370$26.8M73.0%UnusualSEC
May 12, 2020Altshuler DavidEVP, Global Research and CSOForm 4 sale1,304$375k4.3%Plan not statedSEC
May 11, 2020Sachdev AmitEVP, Chief Patient OfficerForm 4 sale10,665$3M23.3%Plan not statedSEC
May 11, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale1,304$373k4.6%Plan not statedSEC
May 7, 2020Sachs Bruce IDirectorForm 4 sale45,000$12.1M80.1%UnusualSEC
May 7, 2020Leiden Jeffrey MExecutive ChairmanForm 4 sale94,369$25.5M69.8%UnusualSEC
May 6, 2020Tatsis OuraniaEVP, Chief Regulatory OfficerForm 4 sale966$263k7.0%Plan not statedSEC
May 6, 2020Silva Paul MSVP & ControllerForm 4 sale1,076$293k6.7%Plan not statedSEC
May 6, 2020Sachdev AmitEVP, Chief Patient OfficerForm 4 sale669$184k1.9%Plan not statedSEC
May 6, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale1,222$333k4.4%Plan not statedSEC
May 6, 2020Kewalramani ReshmaCEO & PresidentForm 4 sale2,074$566k7.2%Plan not statedSEC
May 6, 2020Altshuler DavidEVP, Global Research and CSOForm 4 sale1,222$333k4.1%Plan not statedSEC
May 5, 2020Leiden Jeffrey MExecutive ChairmanForm 4 sale94,372$25.5M66.9%UnusualSEC
May 5, 2020Sachdev AmitEVP, Chief Patient OfficerForm 4 sale57,108$15.1M61.9%UnusualSEC
May 4, 2020Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale1,553$405k4.2%Plan not statedSEC
May 4, 2020Silva Paul MSVP & ControllerForm 4 sale809$211k5.1%Plan not statedSEC
May 4, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale2,330$608k8.0%Plan not statedSEC
May 4, 2020Altshuler DavidEVP, Global Research and CSOForm 4 sale2,330$608k7.5%Plan not statedSEC
Apr 29, 2020Parini MichaelEVP, Chief Adm, Leg & BD OffForm 4 sale2,125$542k7.3%Plan not statedSEC
Apr 28, 2020Lee YuchunDirectorForm 4 sale1,125$290k37.5%UnusualSEC
Apr 27, 2020Lee YuchunDirectorForm 4 sale4,000$1.1M68.1%UnusualSEC
Apr 23, 2020Lee YuchunDirectorForm 4 sale4,000$1.1M68.1%UnusualSEC
Apr 21, 2020Lee YuchunDirectorForm 4 sale4,000$1.1M68.1%UnusualSEC
Apr 13, 2020Silva Paul MSVP & ControllerForm 4 sale859$214k5.4%Plan not statedSEC
Apr 6, 2020Silva Paul MSVP & ControllerForm 4 sale4,891$1.2M24.7%UnusualSEC
Feb 25, 2020Tatsis OuraniaSVP, CROForm 4 sale1,296$302k9.2%Plan not statedSEC
Feb 25, 2020Silva Paul MSVP & ControllerForm 4 sale1,080$252k6.7%Plan not statedSEC
Feb 25, 2020Sachdev AmitEVP, Chief Patient OfficerForm 4 sale3,376$788k9.3%Plan not statedSEC
Feb 25, 2020Parini MichaelEVP, CL&AOForm 4 sale3,028$707k10.1%Plan not statedSEC
Feb 25, 2020Leiden Jeffrey MCEO & PresidentForm 4 sale10,550$2.5M10.2%Plan not statedSEC
Feb 25, 2020Kewalramani ReshmaEVP and CMOForm 4 sale3,634$848k12.0%Plan not statedSEC
Feb 25, 2020Arbuckle Stuart AEVP, Chief Commercial OfficerForm 4 sale3,634$849k9.4%Plan not statedSEC